Dongmei Wang
Clinical Sciences
Executive Vice President and General Manager, CMC Services
M?dicago Inc
China
Biography
"Dr. Dongmei Wang is General Manager of Frontage’s CMC services group. With more than 20 years of pharmaceutical development experience, Dr. Wang’s CMC oversight spans organic synthesis, formulation development, GMP analytical testing, and GMP manufacturing of clinical trial materials. Prior to joining Frontage, Dr. Wang served as the Director of Analytical at NovaDel Pharma Inc., where she led teams in providing support for NDA product development, clinical supplies manufacturing, CMC sections of regulatory filings, and technology transfer to commercial manufacturing sites. Prior to NovaDel, Dr. Wang headed pharmaceutical analysis and control functions at Therics Inc. in product development for 510(k) and IND filings. Earlier in her career, Dr. Wang was a lecturer at the Chinese Academy of Science. Dr. Wang earned a doctor of philosophy degree in chemistry with honors from Iowa State University. She received a master’s of science degree in chemical engineering and a bachelor’s degree in chemistry from Peking University in China.
Research Interest
Clinical data management, Clinical trails, Pharmacovigilance
